Showing results (401-410 of 652) with videos related to

Sort By:
Pageof 66
Annals of Hematology|February 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysisMarco Cerrano, Sylvie Chevret, Emmanuel Raffoux, et al.
The European Respiratory Journal|April 14, 2018
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantationAnne Bergeron, Sylvie Chevret, Régis Peffault de Latour, et al.
The Annals of Thoracic Surgery|February 28, 2012
Similar outcomes after primary and secondary esophagocoloplasty for caustic injuriesMircea Chirica, Helene Vuarnesson, Sarah Zohar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trialsAlexia Iasonos, Mrinal Gounder, David R Spriggs, et al.
Annals of Surgery|July 13, 2010
Late morbidity after colon interposition for corrosive esophageal injury: risk factors, management, and outcome. A 20-years experienceMircea Chirica, Nicolas Veyrie, Nicolas Munoz-Bongrand, et al.
BMC Medical Research Methodology|February 10, 2018
Value of information methods to design a clinical trial in a small population to optimise a health economic utility functionMichael Pearce, Siew Wan Hee, Jason Madan, et al.
Statistical Methods in Medical Research|June 7, 2015
Decision-theoretic designs for small trials and pilot studies: A reviewSiew Wan Hee, Thomas Hamborg, Simon Day, et al.
The New England Journal of Medicine|December 22, 2016
Hypothermia for Neuroprotection in Convulsive Status EpilepticusStephane Legriel, Virginie Lemiale, Maleka Schenck, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2020
Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional StudyElie Azoulay, Alain Cariou, Fabrice Bruneel, et al.
Oncotarget|July 16, 2014
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicinJuliette Lambert, Jérôme Lambert, Olivier Nibourel, et al.
Pageof 66